Table of Contents
Medicated Skin Care in Romania
Euromonitor International
September
2009
List of Contents and Tables
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 1 Sales of
Medicated Skin Care by Subsector: Value 2003-2008
Table 2 Sales of
Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 3 Herbal
vs Standard Medicated Skin Care 2003-2008
Table 4 Acne Treatments by
Format: % Value Breakdown 2004-2008
Table 5 Medicated Skin Care Company
Shares by Value 2004-2008
Table 6 Medicated Skin Care Brand Shares by
Value 2005-2008
Table 7 Acne Treatments Brand Shares by Value
2005-2008
Table 8 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 9 Forecast Sales of Medicated Skin Care by Subsector: Value
2008-2013
Table 10 Forecast Sales of Medicated Skin Care by Subsector: %
Value Growth 2008-2013
Antibiotice SA
Strategic Direction
Key
Facts
Summary 1 Antibiotice SA: Key Facts
Summary 2 Antibiotice SA:
Operational Indicators
Company Background
Production
Competitive
Positioning
Summary 3 Antibiotice SA: Competitive Position 2008
Biofarm SA
Strategic Direction
Key Facts
Summary 4 Biofarm SA: Key
Facts
Summary 5 Biofarm SA: Operational Indicators
Company
Background
Production
Competitive Positioning
Summary 6 Biofarm
SA: Competitive Position 2008
Ozone Laboratories SRL
Strategic
Direction
Key Facts
Summary 7 Ozone Laboratories SRL: Key Facts
Summary 8 Ozone Laboratories SRL: Operational Indicators
Company
Background
Production
Competitive Positioning
Summary 9 Ozone
Laboratories SRL: Competitive Position 2008
Terapia Ranbaxy
Strategic
Direction
Key Facts
Summary 10 Terapia Ranbaxy: Key Facts
Summary
11 Terapia Ranbaxy: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 12 Terapia Ranbaxy:
Competitive Position 2008
Zentiva SA
Strategic Direction
Key
Facts
Summary 13 Zentiva SA: Key Facts
Summary 14 Zentiva SA:
Operational Indicators
Company Background
Production
Competitive
Positioning
Summary 15 Zentiva SA: Competitive Position 2008
Executive
Summary
Excellent Dynamics in 2008
Increased Purchasing Power Sustains
Growth
Domestic Producers Lead the Market
Chemists/pharmacies
Maintains Its Dominance
Changing Lifestyles Increase OTC Consumption
Key Trends and Developments
Ageing Population Drives Market
Performance
Growing Incomes Stimulate Self-medication
OTC Healthcare
Remains Highly Regulated
Modernisation of Pharmacies Contributes To Sales
Growth
Domestic Producers Lead the Market
Rural Areas Represent Strong
Growth Potential
Market Indicators
Table 11 Consumer Expenditure on
Health Goods and Medical Services 2003-2008
Table 12 Life Expectancy at
Birth 2003-2008
Market Data
Table 13 Sales of OTC Healthcare by
Sector: Value 2003-2008
Table 14 Sales of OTC Healthcare by Sector: %
Value Growth 2003-2008
Table 15 OTC Healthcare Company Shares by Value
2004-2008
Table 16 OTC Healthcare Brand Shares by Value 2005-2008
Table 17 Sales of OTC Healthcare by Distribution Format: % Analysis
2003-2008
Table 18 Sales of OTC Healthcare by Sector and Distribution
Format: % Analysis 2008
Table 19 Forecast Sales of OTC Healthcare by
Sector: Value 2008-2013
Table 20 Forecast Sales of OTC Healthcare by
Sector: % Value Growth 2008-2013
Appendix
OTC Registration and
Classification
Vitamins & Dietary Supplements Registration and
Classification
Generics
Switches
Summary 16 OTC Healthcare
Switches 2005-2008
Definitions
Summary 17 Research Sources
| 
View Cart
